Back to All Events

IMI Stakeholder Forum 2017


IMI-2014.jpg

The Innovative Medicines Initiatives (IMI), on behalf of the 13th call for proposals encourages stakeholders in health and medicines R&D to join the Stakeholder Forum: policy makers, academics and researchers, pharmaceutical industry and other sectors with an interest in health research, SMEs and mid-sized enterprises, patient representatives and regulators, representatives of other public-private partnerships and research-funding organisations.

A topic in the scope of Cardiolinc will be “Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches”.

Follow the site of the event for further details and to access the agenda.